Jake Fullen

1.3k total citations
16 papers, 1.1k citations indexed

About

Jake Fullen is a scholar working on Immunology, Ecology, Evolution, Behavior and Systematics and Agronomy and Crop Science. According to data from OpenAlex, Jake Fullen has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 11 papers in Ecology, Evolution, Behavior and Systematics and 11 papers in Agronomy and Crop Science. Recurrent topics in Jake Fullen's work include T-cell and Retrovirus Studies (12 papers), Animal Disease Management and Epidemiology (11 papers) and Vector-Borne Animal Diseases (11 papers). Jake Fullen is often cited by papers focused on T-cell and Retrovirus Studies (12 papers), Animal Disease Management and Epidemiology (11 papers) and Vector-Borne Animal Diseases (11 papers). Jake Fullen collaborates with scholars based in United States, Italy and Poland. Jake Fullen's co-authors include Genoveffa Franchini, James C. Mulloy, Igor J. Koralnik, Christophe Nicot, Risaku Fukumoto, Julie Johnson, Warren J. Leonard, Luca Casareto, P. D. Markham and Robert C. Gallo and has published in prestigious journals such as Nature Medicine, Blood and Journal of Virology.

In The Last Decade

Jake Fullen

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jake Fullen United States 14 988 788 737 123 120 16 1.1k
Bernard Guillemain France 15 798 0.8× 642 0.8× 562 0.8× 68 0.6× 119 1.0× 94 965
Paola Miyazato Japan 16 790 0.8× 648 0.8× 597 0.8× 45 0.4× 132 1.1× 31 967
Harry Paskalis United States 5 661 0.7× 546 0.7× 499 0.7× 69 0.6× 164 1.4× 5 918
Sébastien Alain Chevalier France 17 610 0.6× 493 0.6× 412 0.6× 82 0.7× 179 1.5× 27 813
Anat Melamed United Kingdom 19 1.0k 1.0× 844 1.1× 761 1.0× 72 0.6× 280 2.3× 40 1.3k
I S Chen United States 7 696 0.7× 615 0.8× 579 0.8× 39 0.3× 66 0.6× 8 798
Noreen Sheehy Ireland 15 395 0.4× 307 0.4× 287 0.4× 62 0.5× 174 1.4× 33 676
Chloé Journo France 17 471 0.5× 336 0.4× 309 0.4× 57 0.5× 168 1.4× 34 641
Marianne Van Brussel Belgium 12 435 0.4× 385 0.5× 318 0.4× 182 1.5× 41 0.3× 16 624
Arnaud Florins Belgium 13 703 0.7× 546 0.7× 428 0.6× 21 0.2× 127 1.1× 16 794

Countries citing papers authored by Jake Fullen

Since Specialization
Citations

This map shows the geographic impact of Jake Fullen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jake Fullen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jake Fullen more than expected).

Fields of papers citing papers by Jake Fullen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jake Fullen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jake Fullen. The network helps show where Jake Fullen may publish in the future.

Co-authorship network of co-authors of Jake Fullen

This figure shows the co-authorship network connecting the top 25 collaborators of Jake Fullen. A scholar is included among the top collaborators of Jake Fullen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jake Fullen. Jake Fullen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Nicot, Christophe, Miroslav Dundr, Julie Johnson, et al.. (2004). HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nature Medicine. 10(2). 197–201. 151 indexed citations
2.
Franchini, Genoveffa, Risaku Fukumoto, & Jake Fullen. (2003). T-Cell Control by Human T-Cell Leukemia/Lymphoma Virus Type 1. International Journal of Hematology. 78(4). 280–296. 57 indexed citations
3.
Hel, Zdeněk, Elżbieta Tryniszewska, W P Tsai, et al.. (2002). Design and In Vivo Immunogenicity of a Polyvalent Vaccine Based on SIVmac Regulatory Genes. DNA and Cell Biology. 21(9). 619–626. 8 indexed citations
4.
Johnson, Julie, Christophe Nicot, Jake Fullen, et al.. (2001). Free Major Histocompatibility Complex Class I Heavy Chain Is Preferentially Targeted for Degradation by Human T-Cell Leukemia/Lymphotropic Virus Type 1 p12IProtein. Journal of Virology. 75(13). 6086–6094. 105 indexed citations
5.
Nicot, Christophe, James C. Mulloy, Maria G. Ferrari, et al.. (2001). HTLV-1 p12I protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells. Blood. 98(3). 823–829. 93 indexed citations
6.
Johnson, Julie, James C. Mulloy, Vincenzo Ciminale, et al.. (2000). The MHC Class I Heavy Chain Is a Common Target of the Small Proteins Encoded by the 3′ End of HTLV Type 1 and HTLV Type 2. AIDS Research and Human Retroviruses. 16(16). 1777–1781. 26 indexed citations
7.
Mulloy, James C., Anna Cereseto, Luca Casareto, et al.. (1998). Human T-Cell Lymphotropic/Leukemia Virus Type 1 Tax Abrogates p53-Induced Cell Cycle Arrest and Apoptosis through Its CREB/ATF Functional Domain. Journal of Virology. 72(11). 8852–8860. 145 indexed citations
9.
Franchini, Genoveffa, James Tartaglia, Anita Aggarwal, et al.. (1995). Highly Attenuated HIV Type 2 Recombinant Poxviruses, but Not HIV-2 Recombinant Salmonella Vaccines, Induce Long-Lasting Protection in Rhesus Macaques. AIDS Research and Human Retroviruses. 11(8). 909–920. 48 indexed citations
10.
Franchini, Genoveffa, J. Tartaglia, P. D. Markham, et al.. (1995). Highly Attenuated HTLV Type I env Poxvirus Vaccines Induce Protection against a Cell-Associated HTLV Type I Challenge in Rabbits. AIDS Research and Human Retroviruses. 11(2). 307–313. 42 indexed citations
11.
Koralnik, Igor J., James C. Mulloy, Þorkell Andrésson, Jake Fullen, & Genoveffa Franchini. (1995). Mapping of the intermolecular association of the human T cell leukaemia/lymphotropic virus type I p12I and the vacuolar H+-ATPase 16 kDa subunit protein. Journal of General Virology. 76(8). 1909–1916. 36 indexed citations
12.
Gessain, Antoine, Igor J. Koralnik, Jake Fullen, et al.. (1994). Phylogenetic Study of Ten New HTLV-I Strains from the Americas. AIDS Research and Human Retroviruses. 10(1). 103–106. 21 indexed citations
13.
Koralnik, Igor J., Enzo Boeri, W. Carl Saxinger, et al.. (1994). Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for interspecies transmission. Journal of Virology. 68(4). 2693–2707. 142 indexed citations
14.
Koralnik, Igor J., Jake Fullen, & Genoveffa Franchini. (1993). The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. Journal of Virology. 67(4). 2360–2366. 120 indexed citations
15.
Streicher, Howard, Chia‐Yen Hung, D. V. Ablashi, et al.. (1988). In vitro inhibition of human herpesvirus-6 by phosphonoformate. Journal of Virological Methods. 21(1-4). 301–304. 32 indexed citations
16.
Chirigos, Michael A., William A. Stylos, Richard M. Schultz, & Jake Fullen. (1978). Chemical and biological adjuvants capable of potentiating tumor cell vaccine.. PubMed. 38(4). 1085–91. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026